| | | | | | | | | | |
|
|
|
|
| Dockets Entered On
February 21, 2006
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1980N-0476
|
| Antifungal Drug Products for OTC Human Use
|
|
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| 2000P-0586
|
| Amend Pt 133.3 re:Milk and Nonfat Milk for use in Standardiz
|
|
|
|
|
| 2002D-0325
|
| Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
|
|
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
|
|
| 2003D-0001
|
| Nonclinical Safety Evaluation of Pediatric Drug Products
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| 2004D-0555
|
| Class II Special Controls Draft Guidance; Labeling for Male Condoms Made of Natural Rubber Latex
|
|
|
|
|
| 2005N-0157
|
| Agency Information Collection Activities: Proposed Collection; Postmarketing Adverse Drug Experience Reporting
|
|
|
|
|
| 2005N-0296
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Financial Disclosure by Clinical Investigators
|
|
|
|
|
| 2005N-0354
|
| Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
|
|
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| 1980N-0476
|
| Antifungal Drug Products for OTC Human Use
|
|
|
|
|
| BKG 1
|
| Background material
|
| Vol #:
|
| 13
|
|
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| EMC 4389
|
| C. Brown
|
| Vol #:
|
| 320
|
|
| |
|
| 2000P-0586
|
| Amend Pt 133.3 re:Milk and Nonfat Milk for use in Standardiz
|
|
|
|
|
| EMC 18
|
| R. Sloan
|
| Vol #:
|
| 29
|
|
|
|
|
| EMC 19
|
| B. Vey
|
| Vol #:
|
| 29
|
|
|
|
|
| EMC 20
|
| C. Bucher
|
| Vol #:
|
| 29
|
|
|
|
|
| EMC 21
|
| D. Larson
|
| Vol #:
|
| 29
|
|
|
|
|
| EMC 22
|
| S. Hossain
|
| Vol #:
|
| 29
|
|
|
|
|
| EMC 23
|
| A. Herring
|
| Vol #:
|
| 29
|
|
|
|
|
| EMC 24
|
| L. Miles
|
| Vol #:
|
| 29
|
|
|
|
|
| EMC 25
|
| E. Beighley
|
| Vol #:
|
| 29
|
|
|
|
|
| EMC 26
|
| L. Korte
|
| Vol #:
|
| 29
|
|
|
|
|
| EMC 27
|
| A. Turek
|
| Vol #:
|
| 29
|
|
|
|
|
| EMC 28
|
| T. Petersen
|
| Vol #:
|
| 29
|
|
|
|
|
| EMC 29
|
| D. Sanders
|
| Vol #:
|
| 29
|
|
|
|
|
| EMC 30
|
| D. Mosteiko
|
| Vol #:
|
| 29
|
|
|
|
|
| EMC 31
|
| B. Foti
|
| Vol #:
|
| 29
|
|
|
|
|
| EMC 32
|
| D. Larson
|
| Vol #:
|
| 29
|
|
|
|
|
| EMC 33
|
| J. Belindo
|
| Vol #:
|
| 29
|
|
|
|
|
| EMC 34
|
| A. Vierra
|
| Vol #:
|
| 29
|
|
| | | | | | | | |
|
|
|
|
| EMC
609
|
| Calorie Control Council
|
| Vol #:
|
| 9
|
|
|
|
|
| 2003D-0001
|
| Nonclinical Safety Evaluation of Pediatric Drug Products
|
|
|
|
|
| EMC 2
|
| B. Sachau
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| EMC 1225
|
| H. Eitzen, PhD
|
| Vol #:
|
| 12
|
|
|
|
|
| EMC 1226
|
| H. Eitzen, PhD
|
| Vol #:
|
| 12
|
|
|
|
|
| EMC 1227
|
| S. Zinser
|
| Vol #:
|
| 12
|
|
|
|
|
| EMC 1228
|
| K. Carter
|
| Vol #:
|
| 12
|
|
|
|
|
| EMC 1229
|
| T. Olson
|
| Vol #:
|
| 12
|
|
|
|
|
| EMC 1230
|
| J. Cho
|
| Vol #:
|
| 12
|
|
|
|
|
| EMC 1231
|
| Dr. O'Brien
|
| Vol #:
|
| 12
|
|
|
|
|
| EMC 1232
|
| S. Rodriguez
|
| Vol #:
|
| 12
|
|
|
|
|
| EMC 1233
|
| H. Asche
|
| Vol #:
|
| 12
|
|
|
|
|
| EMC 1234
|
| E. Oaks
|
| Vol #:
|
| 12
|
|
|
|
|
| EMC 1235
|
| T. Coffey
|
| Vol #:
|
| 12
|
|
|
|
|
| EMC 1236
|
| J. Gold
|
| Vol #:
|
| 12
|
|
|
|
|
| 2004D-0555
|
| Class II Special Controls Draft Guidance; Labeling for Male Condoms Made of Natural Rubber Latex
|
|
|
|
|
| EMC
4
|
| National Coalition of STD Directors (NCSD)
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC
5
|
| Urban Coalition for HIV/AIDS Prevention Services (UCHAPS)
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC
6
|
| Center for Disease Control and Prevention (CDC)
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005N-0157
|
| Agency Information Collection Activities: Proposed Collection; Postmarketing Adverse Drug Experience Reporting
|
|
|
|
|
| EMC 2
|
| B. Sachau
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005N-0296
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Financial Disclosure by Clinical Investigators
|
|
|
|
|
| EMC 1
|
| B. Sachau
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005N-0354
|
| Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
|
|
|
|
|
| EMC 321
|
| J. Filippone
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 322
|
| P. Self
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 323
|
| M. Needham
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 324
|
| L. Lee, MD
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 325
|
| R. Ziller
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 326
|
| R. Kistler
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 327
|
| P. Fletcher
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 328
|
| C. Freeman
|
| Vol #:
|
| 11
|
|
